SCHEMBL971061

SCHEMBL971061

COc1ccc(P(c2ccccc2)c2ccc3ccc4cccc5ccc2c3c45)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.39
CYP2A6 P11509 1/20 0.39
ALDH1A1 P00352 7/20 0.38
TDP1 Q9NUW8 4/20 0.38
HPGD P15428 4/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
MAPT P10636 6/20 0.36
KDM4E B2RXH2 4/20 0.36
RAB9A P51151 4/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
GAA P10253 3/20 0.36
CA4 P22748 1/20 0.36
TOP1 P11387 1/20 0.36
LTA4H P09960 1/20 0.36
ERBB2 P04626 1/20 0.36
FYN P06241 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL971382 0.86 CYP1A2 (0.46) CYP1A2ALDH1A1TDP1HPGDL3MBTL1
SCHEMBL29948725 0.86 CYP1A2 (0.46) CYP1A2ALDH1A1TDP1HPGDL3MBTL1
SCHEMBL29556529 0.83 CYP1A2 (0.46) CYP1A2ALDH1A1TDP1HPGDL3MBTL1
SCHEMBL2381659 0.83 CYP1A2 (0.46) CYP1A2ALDH1A1TDP1HPGDL3MBTL1
SCHEMBL7058634 0.82 RAB9A (0.46) CYP1A2CYP2A6ALDH1A1TDP1L3MBTL1
SCHEMBL12947703 0.81 ESR1 (0.52) CYP1A2ALDH1A1TDP1HPGDL3MBTL1
SCHEMBL971042 0.79 ESR1 (0.50) CYP1A2ALDH1A1TDP1HPGDL3MBTL1
SCHEMBL6401400 0.79 RAB9A (0.49) CYP1A2CYP2A6ALDH1A1TDP1HPGD
SCHEMBL301026 0.76 MAPT (0.51) CYP1A2CYP2A6ALDH1A1TDP1L3MBTL1
SCHEMBL12918600 0.76 KCNA3 (0.33) TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420865-B2 Phosphine compound, process for producing the same, and peroxide scavenger using the same FUKUOKA UNIVERSITY (JP) 2013-04-16 US disclosed
US-8420865-B2 Phosphine compound, process for producing the same, and peroxide scavenger using the same FUKUOKA UNIVERSITY (JP) 2013-04-16 US disclosed
US-8420865-B2 Phosphine compound, process for producing the same, and peroxide scavenger using the same FUKUOKA UNIVERSITY (JP) 2013-04-16 US disclosed
US-20110015440-A1 PHOSPHINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PEROXIDE SCAVENGER USING THE SAME FUKUOKA UNIVERSITY (JP) 2011-01-20 US disclosed
US-20110015440-A1 PHOSPHINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PEROXIDE SCAVENGER USING THE SAME FUKUOKA UNIVERSITY (JP) 2011-01-20 US disclosed
US-20110015440-A1 PHOSPHINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PEROXIDE SCAVENGER USING THE SAME FUKUOKA UNIVERSITY (JP) 2011-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015440-A1 PHOSPHINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PEROXIDE SCAVENGER USING THE SAME FECH, PRDX5, MTCH2 CYP1A2 1207/4885CYP2A6 2242/4885ALDH1A1 3057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.